Analysts are not wasting a minute as they are eager to weigh in on beaten biotech stocks Clovis Oncology Inc (NASDAQ:CLVS) and Horizon Pharma PLC …
Clovis Oncology Inc (NASDAQ:CLVS) announced that NASDAQ has halted trading of the Company’s common stock. The U.
In a research report issued Friday, Piper Jaffray analyst Joshua Schimmer reiterated a Neutral rating on shares of Clovis Oncology Inc (NASDAQ:CLVS) with a price …
Clovis Oncology Inc (NASDAQ:CLVS) reported financial results for its quarter and year ended December 31, 2015, and provided an update on the Company’s clinical …
Clovis Oncology Inc (NASDAQ:CLVS) that the U.S.
Clovis Oncology Inc (NASDAQ:CLVS) announced that it initiated a clinical trial to evaluate a novel combination therapy of Genentech’s investigational cancer immunotherapy atezolizumab (MPDL3280A; …
Clovis Oncology Inc (NASDAQ:CLVS) announced that Dale Hookshas been named Senior Vice President and Chief Commercial Officer. Mr.
Yesterday was a great day for biotech stocks. The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks 144 biotech and pharmaceutical companies, reversed losses and surged …
Clovis Oncology Inc (NASDAQ:CLVS) announced that the U.S.
Sunedison Inc (NYSE:SUNE) shares are up nearly 5% to $3.41, rebounding from falls on Wednesday after UBS research analyst Julien Dumoulin Smith downgraded the …
